4
Changes in Ownership
Vistagen Therapeutics, Inc. Filed Acc 0001415889-21-003389
PRES./CHIEF SCIENTIFIC OFFICER acquired 3,391 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| SNODGRASS H. RALPH PRES./CHIEF SCIENTIFIC OFFICER | 2021-06-30 | Grant or award | +3,391 | $1.95 | $6,601 | 91,115 | D |
Loading xslF345X03/form4-07022021_040716.xml…